Salvador González‐Ochoa

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Mexican Social Security Institute(Current)

Universidad de Guadalajara

Salvador González‐Ochoa is an author at Mexican Social Security Institute specializing in cancer immunotherapy, growth factors, and cytokine receptor signaling.

Publications per year

2019–2022

Publications

Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis

Aníbal Samael Méndez-Clemente, Alejandro Bravo‐Cuéllar, Salvador González‐Ochoa et al. · Oncology Reports · 2022 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells

Salvador González‐Ochoa, Martha Cecilia Téllez‐Bañuelos, Aníbal Samael Méndez-Clemente et al. · Journal of Immunology Research · 2022 · 16 citations · Full text

Life Sciences, Oncology, Pharmacology +14

Low-dose endosulfan inhibits proliferation and induces senescence and pro-inflammatory cytokine production in human lymphocytes, preferentially impacting cytotoxic cells

Martha Cecilia Téllez‐Bañuelos, Salvador González‐Ochoa, Pablo Cesar Ortiz‐Lazareno et al. · Journal of Immunotoxicology · 2019 · 13 citations · Full text

Pharmacy, Immunology, Toxicology +17

1–3 of 3